Gregory Sawicki is a Respiratory physician. OpenAlex indexes 391 publications with 17,739 citations (h-index 71); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pediatric Pulmonology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Longwood Avenue
Childrens Hospital
Boston, MA 02115
Telephone
617-355-6105Registry record last updated 8 Jul 2007.
Clinical trials
- Qualitative Understanding of Experiences With the SIMPLIFY Trial
Sponsor: Boston Children's Hospital
- Optimizing Ankle Exoskeleton Assistance for Walking Across the Life Span
Sponsor: Georgia Institute of Technology
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20259 payments
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20242 payments
- ABBVIE INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
100%beta2-Adrenergic Agonist100%Albuterol Sulfate Hfa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2011–2015 per NIH RePORTER. The latest:
- Cystic Fibrosis as a Model of Health Care Transition for Chronically Ill Youth
Boston Children'S Hospital
FY2015$139,174K23HL105541 - Cystic Fibrosis as a Model of Health Care Transition for Chronically Ill Youth
Boston Children'S Hospital
FY2014$139,714K23HL105541 - Cystic Fibrosis as a Model of Health Care Transition for Chronically Ill Youth
Boston Children'S Hospital
FY2013$139,714K23HL105541
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome
Journal of Allergy and Clinical Immunology
2022 - The exoskeleton expansion: improving walking and running economy
Journal of NeuroEngineering and Rehabilitation
2020 - Ivacaftor in Infants Aged 4 to &lt;12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial
American Journal of Respiratory and Critical Care Medicine
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”